Integrated Diagnostics (LON:IDHC) Sets New 12-Month High – Here’s Why

Integrated Diagnostics Holdings plc (LON:IDHC)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 0.73 and last traded at GBX 0.73, with a volume of 71006 shares. The stock had previously closed at GBX 0.70.

Integrated Diagnostics Stock Up 0.7%

The firm’s 50-day moving average price is GBX 0.64 and its 200 day moving average price is GBX 0.51. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 45.72. The company has a market capitalization of £4.39 million, a price-to-earnings ratio of 0.00, a PEG ratio of 7.65 and a beta of 0.59.

About Integrated Diagnostics

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.